Stella Pharma (TSE:4888) Long-Term Debt : 円693.3 Mil (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Stella Pharma Long-Term Debt?

Stella Pharma's Long-Term Debt for the quarter that ended in Sep. 2024 was 円693.3 Mil.

Stella Pharma's quarterly Long-Term Debt declined from Dec. 2023 (円813.3 Mil) to Mar. 2024 (円773.3 Mil) and declined from Mar. 2024 (円773.3 Mil) to Sep. 2024 (円693.3 Mil).

Stella Pharma's annual Long-Term Debt declined from Mar. 2022 (円1,093.3 Mil) to Mar. 2023 (円933.3 Mil) and declined from Mar. 2023 (円933.3 Mil) to Mar. 2024 (円773.3 Mil).

Stella Pharma Long-Term Debt Historical Data

The historical data trend for Stella Pharma's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stella Pharma Long-Term Debt Chart

Stella Pharma Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Long-Term Debt

Get a 7-Day Free Trial

1,413.32

1,253.32

1,093.31

933.30

773.29

Stella Pharma Quarterly Data
	Mar19	Mar20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Sep24
Long-Term Debt	Get a 7-Day Free Trial												893.30	853.30	813.29	773.29	693.29

Stella Pharma (TSE:4888) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Stella Pharma Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Stella Pharma's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Stella Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stella Pharma Corp (TSE:4888) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

3-2-7 Korai-bashi, Chuo-ku, Osaka Prefecture, Osaka, JPN, 541-0043

Website

https://stella-pharma.co.jp

Stella Pharma Corp is a therapeutic drug research and development company. It is focused on the development of boron compounds, particularly used in boron neutron capture therapy (BNCT). The BNCT is a form of cancer radiation therapy for destroying cancer cells.

Stella Pharma Headlines

No Headlines